| Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells. Cho S., Lu M., He X., Ee P.L., Bhat U., Schneider E., Miele L., Beck W.T.
Proc. Natl. Acad. Sci. U.S.A. 108:20778-20783(2011) · Mapped (3) |
| Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine. Natarajan K., Xie Y., Nakanishi T., Beck W.T., Bauer K.S., Ross D.D.
Biochim. Biophys. Acta 1809:295-305(2011) · UniProtKB (4) · Mapped (2) |
| Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIalpha and drug responsiveness. Chen C.F., He X., Arslan A.D., Mo Y.Y., Reinhold W.C., Pommier Y., Beck W.T.
Mol. Pharmacol. 79:735-741(2011) · Mapped (2) |
| Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. He X., Arslan A.D., Pool M.D., Ho T.T., Darcy K.M., Coon J.S., Beck W.T.
Oncogene 30:356-365(2011) · Mapped (3) |
| Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. Kuhn D.E., Nuovo G.J., Terry A.V. Jr., Martin M.M., Malana G.E., Sansom S.E., Pleister A.P., Beck W.D., Head E., Feldman D.S. et al.
J. Biol. Chem. 285:1529-1543(2010) · Mapped (16) |
| Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors. Wang Y., Beck W., Deppisch R., Marshall S.M., Hoenich N.A., Thompson M.G.
Am. J. Physiol., Cell Physiol. 293:C328-36(2007) · Mapped (4) |
| Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing. Terry A.V. Jr., Gearhart D.A., Beck W.D. Jr., Truan J.N., Middlemore M.L., Williamson L.N., Bartlett M.G., Prendergast M.A., Sickles D.W., Buccafusco J.J.
J. Pharmacol. Exp. Ther. 322:1117-1128(2007) · Mapped (1) |
| Topoisomerase II binds importin alpha isoforms and exportin/CRM1 but does not shuttle between the nucleus and cytoplasm in proliferating cells. Mirski S.E., Sparks K.E., Friedrich B., Kohler M., Mo Y.Y., Beck W.T., Cole S.P.
Exp. Cell Res. 313:627-637(2007) · Mapped (9) |
| A role for Ubc9 in tumorigenesis. Mo Y.Y., Yu Y., Theodosiou E., Ee P.L., Beck W.T.
Oncogene 24:2677-2683(2005) · Mapped (4) |
| Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs. Mo Y.Y., Yu Y., Ee P.L., Beck W.T.
Cancer Res. 64:2793-2798(2004) · Mapped (3) |
| Sumoylation of topoisomerase I is involved in its partitioning between nucleoli and nucleoplasm and its clearing from nucleoli in response to camptothecin. Rallabhandi P., Hashimoto K., Mo Y.-Y., Beck W.T., Moitra P.K., D'Arpa P.
J. Biol. Chem. 277:40020-40026(2002) · UniProtKB (1) · Mapped (4) |
| A novel nuclear localization signal in human DNA topoisomerase I. Mo Y.Y., Wang C., Beck W.T.
J. Biol. Chem. 275:41107-41113(2000) · Mapped (6) |
| Drug resistance associated with altered DNA topoisomerase II. Beck W.T., Danks M.K., Wolverton J.S., Kim R., Chen M.
Adv. Enzyme Regul. 33:113-127(1993) · Mapped (1) |
| HPLC separation of enterobactin and linear 2,3-dihydroxybenzoylserine derivatives: a study on mutants of Escherichia coli defective in regulation (fur), esterase (fes) and transport (fepA). Winkelmann G., Cansier A., Beck W., Jung G.
Biometals 7:149-154(1994) |
| IS431, a staphylococcal insertion sequence-like element related to IS26 from Proteus vulgaris. Barberis-Maino L., Berger-Baechi B., Weber H., Beck W.D., Kayser F.H.
Gene 59:107-113(1987) · UniProtKB (3) |
| Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide. Bugg B.Y., Danks M.K., Beck W.T., Suttle D.P.
Proc. Natl. Acad. Sci. U.S.A. 88:7654-7658(1991) · UniProtKB (1) |
| Isolation and characterization of the three polypeptide components of 4-chlorobenzoate dehalogenase from Pseudomonas sp. strain CBS-3. Chang K.H., Liang P.H., Beck W., Scholten J.D., Dunaway-Mariano D.
Biochemistry 31:5605-5610(1992) · UniProtKB (5) |
| Structure-activity studies of amsacrine analogs in drug resistant human leukemia cell lines expressing either altered DNA topoisomerase II or P-glycoprotein. Granzen B., Graves D.E., Baguley B.C., Danks M.K., Beck W.T.
Oncol. Res. 4:489-496(1992) · Mapped (1) |
